Cytogenetic analysis of a primary salivary gland myoepithelioma

Cancer Genetics and Cytogenetics

Volumn 113, Issue 1, 1999, Pages 49-53

  El Naggar, Adel K ^a   Lovell, Mercedes ^a   Callender, David L ^a   Ordonez, Nelson G ^a   Killary, Ann M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 12Q; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MYOEPITHELIOMA; PAROTID GLAND; PRIORITY JOURNAL; SALIVARY GLAND TUMOR;

ACTINS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 9; DESMIN; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; KERATINS; MALE; MIDDLE AGED; MYOEPITHELIOMA; SALIVARY GLAND NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 0032839437     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00280-5     Document Type: Article

References (42)

1. Leifer C., Miller A.S., Putong P.B., Harwick R.D. Myoepithelioma of the parotid gland. Arch Pathol. 88:1974;312-319.
2. Sciubba J.J., Brannon R.B. Myoepithelioma of salivary glands. report of 23 cases Cancer. 49:1982;562-572.
3. Dardick I., Van Nostrand A.W. Myoepithelial cells in salivary tumor. Head Neck Surg. 7:1985;395-408.
4. Morinaga S., Nakajima T., Shimosato Y. Normal and neoplastic myoepithelial cells in salivary glands. an immunohistochemical study Hum Pathol. 18:1987;1218-1226.
5. Dardick I., Ostrynski V.L., Ekem J.K., Leung R., Burford-Mason A.P. Immunohistochemical and structural correlated of muscle-actin expression in pleomorphic adenomas and myoepitheliomas based on comparison of formalin and methanol fixation. Virchows Arch A. 421:1992;95-104.
6. Dardick I., Van Nostrand A.W., Phillips M.J. Histogenesis of salivary gland pleomorphic adenomas (mixed tumor) with an evaluation of the role of the myoepithelial cell. Hum Path. 13:1982;62-75.
7. Erlandson R.A., Cardon-Cardo C., Higgins P.J. Histogenesis of benign pleomorphic adenoma (mixed tumor) of the major salivary glands. An ultrastructural and immunohistochemical study. Am J Surg Pathol. 8:1984;803-820.
8. Nikai H., Ogawa I., Ijuhin N., Yamasaki I.A., Takata T., Elbardaie A. Ultrastructural cytochemical demonstration of elastin in the matrix of salivary gland tumors. Acta Pathol Jpn. 33:1983;1171-1178.
9. David R., Buchner A. Elastosis in benign and malignant salivary gland tumors. A histochemical and ultrastructural study. Cancer. 45:1980;2301-2310.
10. Mark J., Dahlenfors R. Cytogenetical observations in 100 human benign pleomorphic adenomas. specificity of the chromosomal aberrations and their relationship to sites of localized oncogenes Anticancer Res. 6:1986;299-308.
11. Bullerdiek J., Böschen C., Bartnitzke S. Aberrations of chromosome #8 in mixed salivary gland tumors. Cancer Genet Cytogenet. 24:1987;205-212.
12. Bullerdiek J., Raabe G., Bartnitzke S., Böschen C., Schloot W. Structural rearrangements of chromosome #8 involving 8q12. a primary event in pleomorphic adenomas of the parotid gland Genetics. 72:1987;85-92.
13. Bullerdiek J., Bartnitzke S., Weinberg M., Chilla R., Haubrich J., Schloot W. Rearrangement of chromosome region 12q13-15 in pleomorphic adenomas of the human salivary gland (PSA). Cytogenet Cell Genet. 45:1987;187-190.
14. Bullerdiek J., Takla G., Bartnitzke S., Brandt G., Chilla R., Haubrich J. Relationship of cytogenetic subtypes of salivary gland pleomorphic adenomas with patient age and histologic type. Cancer. 64:1989;876-880.
15. Bullerdiek J., Wobst G., Meyer-Boltek K., Chilla R., Haubrich J., Thode B., Bartnitzke S. Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas. correlation of occurrence, histological subtype and in-vitro cellular behavior Cancer Genet Cytogenet. 65:1993;27-31.
16. Sreekantaiah C., Sandberg A.A. Clustering of aberrations to specific chromosome regions in benign neoplasms. Int J Cancer. 48:1991;194-198.
17. Sahlin P., Mark J., Stenman G. Detection of hidden structural rearrangements by FISH in pleomorphic adenomas. Genes Chromosom Cancer. 12:1995;81-86.
18. Fletcher J.A. Translocation (12;22)(q13-14;q12) is a nonrandom aberration in soft-tissue clear-cell sarcoma. Genes Chromosom Cancer. 5:1992;184.
19. Sahlin P., Mark J., Stenman G. Submicroscopic deletions of 3p sequences in pleomorphic adenomas with t(3;8) (p21;q12). Genes Chromosom Cancer. 10:1994;256-261.
20. Jenkins R.B., Kimmell D.W., Moertel C.A., Schulz C.A., Menezes R.M., Scheilhuer B., Kelly P.J., Dewald G.W. Recurrent cytogenetic abnormalities in 80 gliomas. Cytogenet Cell Genet. 51:1989;1019.
21. Kools P.F.J., Wanschura S., Schoenmakers E.F., Geurts J.W.M., Mols R., Kazmierczak B., Bullerdiek J., Van den Berghe H., Van de Ven W.J.M. Identification of the chromosome 12 translocation breakpoint region of a pleomorphic salivary gland adenoma with t(1;12)(p22;q15) as the sole cytogenetic abnormality. Cancer Genet Cytogenet. 79:1995;1-7.
22. Mandahl N., Orndal C., Heim S., Willen H., Rydholm A., Bauer H.C.F., Mitelman F. Aberrations of chromosome segment 12q13-15 characterize a subgroup of hemangiopericytomas. Cancer. 71:1993;3009-3013.
23. Mandahl N., Willen H., Rydholm A., Mitelman F. Rearrangement of brand q13 on both chromosomes 12 in a periosteal chondroma. Genes Chromosom Cancer. 6:1993;121-123.
24. Nilbert M., Heim S. Uterine leiomyoma cytogenetics. Genes Chromosom Cancer. 2:1990;3-13.
25. Noguera R., Llombart-Bosch A., Lopez-Gines C., Carda C., Fernandez C.I. Giant-cell tumor of bone, stage II, displaying translocation t(12;19)(q13q13). Virchows Arch A. 415:1989;377-382.
26. Pandis N., Heim S., Bardi G., Florérus U.-M., Willén H., Mandahl N., Mitelman F. Chromosome analysis of 96 uterine leiomyomas. Cancer Genet Cytogenet. 55:1991;11-18.
27. Reeves B.R., Fletcher C.D.M., Gusterson B.A. Translocation t(12;22) (q13;q13) is a nonrandom rearrangement in clear cell sarcoma. Cancer Genet Cytogenet. 64:1992;101-103.
28. Roberts P., Browne C.F., Lewis I.J., Bailey C.C., Spice R.B., William J., Batcup G. 12q13 Abnormality in rhabdomyosarcoma. A nonrandom occurrence? Cancer Genet Cytogenet. 60:1992;135-140.
29. Schoenmakers E.F., Kools P.F.J., Kazmierczak B., Bullerdiek J., Claussen U., Horsthemke B., Van den Berghe H., Van de Ven J.M. Isolation of a somatic cell hybrid retaining the der(16)t(12;16)(q13;p11.2) from a myxoid liposarcoma cell line. Cancer Genet Cytogenet. 62:1993;159-161.
30. Vanni R., Dal Cin P., Marras S., Moeman Ph Andria M., Valdes E., Deprest J., Van den Berghe H. Endometrial polyp. another benign tumor characterized by 12q13-15 changes Cancer Genet Cytogenet. 68:1993;32-33.
31. Wanschura S., Belge G., Stenman G., Kools P., Dal Cin P., Schoenmakers E.F., Huysmans C., Bartnitzke S., Van de Ven W., Bullerdiek J. Mapping of the translocation breakpoints of primary pleomorphic adenomas and lipomas within a common region of chromosome 12. Cancer Genet Cytogenet. 86:1996;39-45.
32. Pathak S. Chromosome banding techniques. J Reprod Med. 17:1976;25-28.
33. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
34. Traganos F., Darzynkiewicz Z., Sharpless T., Melamed M.R. Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytometric system. J Histohcem Cytochem. 25:1977;46-56.
35. Hsu H.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. a comparison between ABC and unlabeled (PAP) procedures J Histohcem Cytochem. 29:1981;577-580.
36. Van de Ven W.J.M., Schoenmakers E.F., Wanschura S., Kazmierczak B., Kools P.F.J., Geurts J.M.W., Bartnitzke S., Berghe H.V.D., Bullerdiek J. Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-15 implicated in various solid tumors. Genes Chromosom Cancer. 12:1995;296-303.
37. Schoenmakers E.F., Kools P.F., Mols R., Kazmierczak B., Bartnitzke S., Bullerdiek J., Dal Cin P., DeJong P.J., Van den Berghe H., Van de Ven W.J.M. Physical mapping of chromosome 12q breakpoint in lipoma, pleomorphic salivary gland adenoma, uterine leiomyoma, and myxoid liposarcoma. Genomics. 20:1994;210-222.
38. Schoenmakers E.F., Wanschura S., Mols R., Bullerdiek J., Van den Berghe H., Van de Ven W.J.M. Recurrent rearrangements in the high mobility group protein gene HMGI-C, in benign mesenchymal tumors. Nature Genet. 10:1995;436-443.
39. Amman P., Ron D., Mandahl N., Fioretos T., Heim S., Arheden K., Willen H., Rydholm A., Mitelman F. Rearrangement of the transcription factor gene CHOP in myxoid liposarcoma with t(12;16)(q13;p11). Genes Chromosom Cancer. 5:1992;278-285.
40. Rabbits T.H., Forster A., Larson R., Nathan P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nature Genet. 4:1993;175-180.
41. Schoenmakers E.F., Mols R., Wanschura S., Kools P.F.J., Geurts J.M.W., Bartnitzke S., Bullerdiek J., Van de Berghe H., Van de Ven W.J.M. Identification, molecular cloning and characterization of the chromosome 12 breakpoint cluster region of uterine leiomyoma. Genes Chromosom Cancer. 11:1994;106-118.
42. Sreekantaiah C., Leong S.L.P., Karakousis C.P., McGree D.L., Rappaport W.D., Villar H.V., Neal D., Fleming S., Wankel A., Herrington P.N., Carmona R., Sandberg A.A. Cytogenetic profile of 109 lipomas. Cancer Res. 51:1991;422-433.